Literature DB >> 23348834

White matter fractional anisotropy is inversely related to anxious symptoms in older adults with atherosclerosis.

Kelly R Bijanki1, Ashley N Stillman, Stephan Arndt, Vincent A Magnotta, Jess G Fiedorowicz, William G Haynes, Joy T Matsui, Hans J Johnson, David J Moser.   

Abstract

OBJECTIVE: Clinical anxiety disorders are associated with white matter hyperintensities and diffusion abnormalities measured using diffusion tensor imaging. However, it is not known if this association extends into individuals with mild anxious symptoms without formal diagnosis, in those who are older, or in those who have atherosclerosis. The current study explores whether white matter integrity and/or organization significantly associates with anxious symptoms in older adults with and without atherosclerosis.
METHODS: We recruited older adults (ages 55-90 years); 35 with clinically diagnosed atherosclerotic vascular disease (AVD) and 22 without AVD. Anxious symptoms were measured using the validated Symptom Checklist-90-Revised. Fractional anisotropy (FA), a proxy for white matter organization and health, was measured in the white matter globally, by lobe, and in several smaller regions of interest suggested by the literature. Partial correlations between anxious symptoms and FA were calculated, controlling for significant covariates.
RESULTS: Participants with and without AVD did not differ in severity of anxious symptom endorsement. There was a unique inverse relationship between white matter health and anxious symptoms in the AVD participants, but not in healthy comparisons. Significant relationships were observed in the superior longitudinal fasciculus (r = -0.476, df = 32, p = 0.004), as well as the cingulum bundle, the frontal lobes, and the parietal lobes.
CONCLUSIONS: Anxiety symptoms uniquely correlated with low FA in older adults with atherosclerosis. These findings may have implications for future research on the topic of anxiety in aging and vascular disease and warrant replication.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  anxiety; cingulum; diffusion tensor imaging; longitudinal fasciculus; uncinate

Mesh:

Year:  2013        PMID: 23348834      PMCID: PMC3690172          DOI: 10.1002/gps.3930

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  36 in total

1.  Primary and subsequent coronary risk appraisal: new results from the Framingham study.

Authors:  R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

2.  Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study.

Authors:  D M Moody; M A Bell; V R Challa
Journal:  AJNR Am J Neuroradiol       Date:  1990-05       Impact factor: 3.825

3.  Anxious symptoms and cognitive function in non-demented older adults: an inverse relationship.

Authors:  Ashley N Stillman; Kelly C Rowe; Stephan Arndt; David J Moser
Journal:  Int J Geriatr Psychiatry       Date:  2011-09-15       Impact factor: 3.485

4.  The Brief Symptom Inventory: an introductory report.

Authors:  L R Derogatis; N Melisaratos
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

5.  Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.

Authors:  Spilios V Argyropoulos; Sean D Hood; Mariona Adrover; Caroline J Bell; Ann S Rich; Jon R Nash; Neil C Rich; Harry J Witchel; David J Nutt
Journal:  Biol Psychiatry       Date:  2004-10-01       Impact factor: 13.382

6.  Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors.

Authors:  Warren D Taylor; James R MacFall; James M Provenzale; Martha E Payne; Douglas R McQuoid; David C Steffens; K Ranga Rama Krishnan
Journal:  AJR Am J Roentgenol       Date:  2003-08       Impact factor: 3.959

7.  Factor structure and discriminant validity of the SCL-90 in a veteran psychiatric population.

Authors:  A Clark; M J Friedman
Journal:  J Pers Assess       Date:  1983-08

8.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  Influence of exercise on anxiety level in patients with anxiety disorders.

Authors:  O G Cameron; C J Hudson
Journal:  Psychosomatics       Date:  1986-10       Impact factor: 2.386

Review 10.  Neuroanatomical circuits modulating fear and anxiety behaviors.

Authors:  D S Charney
Journal:  Acta Psychiatr Scand Suppl       Date:  2003
View more
  9 in total

1.  Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes.

Authors:  Laura M Raffield; Gretchen A Brenes; Amanda J Cox; Barry I Freedman; Christina E Hugenschmidt; Fang-Chi Hsu; Jianzhao Xu; Benjamin C Wagner; Jeff D Williamson; Joseph A Maldjian; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2015-09-25       Impact factor: 2.852

2.  Age-related reduced prefrontal-amygdala structural connectivity is associated with lower trait anxiety.

Authors:  David Clewett; Shelby Bachman; Mara Mather
Journal:  Neuropsychology       Date:  2014-03-17       Impact factor: 3.295

3.  Quantifying the axonal pathways directly stimulated in therapeutic subcallosal cingulate deep brain stimulation.

Authors:  Bryan Howell; Ki Sueng Choi; Kabilar Gunalan; Justin Rajendra; Helen S Mayberg; Cameron C McIntyre
Journal:  Hum Brain Mapp       Date:  2018-10-11       Impact factor: 5.038

4.  Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study.

Authors:  Thomas T van Sloten; Sigurdur Sigurdsson; Mark A van Buchem; Caroline L Phillips; Palmi V Jonsson; Jie Ding; Miranda T Schram; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer
Journal:  Am J Psychiatry       Date:  2015-03-03       Impact factor: 18.112

5.  The synergistic effects of anxiety and cerebral hypoperfusion on cognitive dysfunction in older adults with cardiovascular disease.

Authors:  Michael L Alosco; John Gunstad; Courtney Beard; Xiaomeng Xu; Uraina S Clark; Donald R Labbe; Beth A Jerskey; Maura Ladino; Denise M Cote; Edward G Walsh; Athena Poppas; Ronald A Cohen; Lawrence H Sweet
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-07-09       Impact factor: 2.680

6.  Preliminary Evidence for the Impact of Combat Experiences on Gray Matter Volume of the Posterior Insula.

Authors:  Ashley N Clausen; Sandra A Billinger; Jason-Flor V Sisante; Hideo Suzuki; Robin L Aupperle
Journal:  Front Psychol       Date:  2017-12-12

7.  Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson's Disease.

Authors:  Camilla Elefante; Giulio Emilio Brancati; Silvia Bacciardi; Sonia Mazzucchi; Eleonora Del Prete; Giovanni Palermo; Daniela Frosini; Ubaldo Bonuccelli; Roberto Ceravolo; Lorenzo Lattanzi; Icro Maremmani; Giulio Perugi
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

8.  Depressive symptoms related to low fractional anisotropy of white matter underlying the right ventral anterior cingulate in older adults with atherosclerotic vascular disease.

Authors:  Kelly R Bijanki; Joy T Matsui; Helen S Mayberg; Vincent A Magnotta; Stephan Arndt; Hans J Johnson; Peg Nopoulos; Sergio Paradiso; Laurie M McCormick; Jess G Fiedorowicz; Eric A Epping; David J Moser
Journal:  Front Hum Neurosci       Date:  2015-07-15       Impact factor: 3.169

9.  Disruption of the structural and functional connectivity of the frontoparietal network underlies symptomatic anxiety in late-life depression.

Authors:  Hui Li; Xiao Lin; Lin Liu; Sizhen Su; Ximei Zhu; Yongbo Zheng; Weizhen Huang; Jianyu Que; Le Shi; Yanping Bao; Lin Lu; Jiahui Deng; Xinyu Sun
Journal:  Neuroimage Clin       Date:  2020-08-28       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.